Trading Update

RNS Number : 7526R
EMIS Group PLC
08 July 2022
 

 

8 July 2022

 

EMIS Group plc

("EMIS Group" or "the Group")

 

Trading update

 

 

 

EMIS Group plc (AIM: EMIS.L), a UK leader in connected healthcare software and systems, today announces a trading update for the six months ended 30 June 2022.

 

Trading for the half year continued to track in line with the Board's expectations. The Group retained its leading positions in specialist markets, benefited from high levels of recurring revenue and remained in a strong financial position. 

 

In EMIS Health, the Group is continuing to support its customers across the NHS while accelerating investment in its technology and cloud refresh strategy as well as in improved internal systems. As expected, revenue growth was held back by a planned reduction in lower margin resale partner activities. However, the business will benefit from a number of digitisation contracts which were secured for delivery in the second half of the year.

 

In EMIS Enterprise ,  the Group continues to execute in the areas of analytics, patient-facing services and pharmacy, with encouraging contributions from the two acquisitions completed in the period adding to double digit organic growth in revenues in the first half.

 

The Group retains a strong balance sheet position with net cash at 30 June 2022 of 53.6m (30 June 2021: 48.0m).

 

 

 

For further information, contact:

 

EMIS Group plc      Tel: 0330 024 1269

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

 

Numis Securities Limited (Nominated Adviser & Broker)  Tel: 020 7260 1000

Joshua Hughes/Simon Willis/James Black

 

MHP Communications  Tel: 020 3128 8567

Reg Hoare/ Matthew Taylor/Pauline Guenot    emis@mhpc.com 

 

Information for investors can be found on the Group's website at www.emisgroupplc.com/investors .

 

 

Notes to Editors

 

EMIS Group has grown to become a UK leader in connected healthcare software and systems. Its solutions are widely used across a number of major UK healthcare settings. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

 

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

 

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

 

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services, data and analytics, and research and life sciences.  

 

 

 

LEI: 213800K474ZZK76NX913

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUQCMUPPGAM

Companies

EMIS Group (EMIS)
UK 100

Latest directors dealings